US FDA approves ViiV Healthcare’s Cabenuva as complete long-acting regimen for HIV treatment
Cabenuva allows virologically suppressed adults living with HIV without prior treatment failure or resistance to cabotegravir or…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
ViiV Healthcare
FDA approves drug to treat infants and children with HIV
The safety and effectiveness of Tivicay and Tivicay PD were supported by a trial that included 75 HIV-1–infected infants, children…
US FDA declines to approve GSK drugs division’s long acting HIV injection
ViiV, in which Pfizer and Shionogi have small stakes, said it received a so-called complete response letter (CRL) from the FDA in…
GSK’s Dovato suppresses AIDS virus at same levels of three-drug regimen
The positive results further bolster GSK’s efforts to challenge US drugmaker Gilead, which currently leads the HIV treatment…
Lupin receives US FDA approval for Epivir tabs
Would commence marketing the product shortly